Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simethicone administration methods in colonoscopy
NCT06919120Phase 4Not yet recruiting
- Sponsor
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jun 2025
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of simethicone in intestinal gas (2 arms), sponsored by The Fourth Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoints: Boston Bowel Preparation Scale and Intestinal Bubble Score. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
simethicone
03
Conditions
intestinal gas
Beyond the preview
Go deeper on NCT06919120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06919120.